Home glucose test for type 1 diabetes screening
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at whether you can do an oral glucose tolerance test at home instead of at a clinic. It is for people who have certain antibodies linked to type 1 diabetes or who were recently diagnosed with type 1 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You weigh at least 95 pounds (43 kg)
- You have at least one islet autoantibody or were diagnosed with type 1 diabetes in the last 100 days
- You are generally healthy and not pregnant
- You are not taking SGLT inhibitor medicines for diabetes
- You have not donated blood in the past 8 weeks
- You can understand spoken and written English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well “good cholesterol” (HDL) works in people with type 1 diabetes, especially when kidney tests show early or more advanced damage. Researchers will compare different groups (normal, micro-, and macro-albumin in urine) to better understand HDL’s role and how it may relate to kidney health.
This study looks at using a finger-prick test instead of a standard blood draw for the oral glucose tolerance test (OGTT), which measures how your body handles sugar. It may help young people at risk for or with early type 1 diabetes avoid repeated needle sticks.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
This study uses a continuous glucose monitor (CGM) and an oral glucose tolerance test (OGTT) to check how well your body controls blood sugar. It is for people who may have early signs of diabetes or are at risk and want to better understand their glucose health.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This study looks at how people with type 1 diabetes are treated and how their metabolism is doing. It will help doctors understand the condition better and improve care.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.